JAGX
JAGX
NASDAQ · Pharmaceuticals

Jaguar Health Inc

$0.40
0.00 (-0.50%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +11,959.4% upside
Low Target $35.39
Average Target $47.90
High Target $54.68
Current Price $0.40
Current
$0.40
Target
$47.90
$35.39 $47.90 avg $54.68
Scenario Analysis
Bear Case
$35.39
8,809.9%
Low target
Base Case
$47.90
+11,959.4%
Avg target
Bull Case
$54.68
+13,666.4%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$15.48
-97.4% from high
52-Week Low
$0.40
+-0.7% from low
Target vs 52W High
$47.90
+209.4% vs high
Next Earnings Report
Mar 30, 2026 · After Market Close
3d
until earnings
EPS Est: $-4.35
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%